Page last updated: 2024-10-16

gamma-aminobutyric acid and Bradykinesia

gamma-aminobutyric acid has been researched along with Bradykinesia in 6 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"Patients with Parkinson's disease (PD) show impaired short-term potentiation (STP) mechanisms in the primary motor cortex (M1)."1.91Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease. ( Berardelli, A; Bologna, M; Cannavacciuolo, A; Colella, D; Fabbrini, G; Giangrosso, M; Guerra, A; Paparella, G, 2023)
"Bradykinesia is a prominent phenotype of Parkinson's disease, depression, and other neurological conditions."1.43Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling. ( Alvarez, VA; Friend, DM; Kaplan, AR; Kravitz, AV; Lemos, JC; Rubinstein, M; Shin, JH, 2016)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Guerra, A1
Colella, D1
Cannavacciuolo, A1
Giangrosso, M1
Paparella, G1
Fabbrini, G1
Berardelli, A1
Bologna, M1
Smith, KM1
Browne, SE1
Jayaraman, S1
Bleickardt, CJ1
Hodge, LM1
Lis, E1
Yao, L1
Rittle, SL1
Innocent, N1
Mullins, DE1
Boykow, G1
Reynolds, IJ1
Hill, D1
Parker, EM1
Hodgson, RA1
El Zahaf, NA1
Salem Elhwuegi, A1
Lemos, JC1
Friend, DM1
Kaplan, AR1
Shin, JH1
Rubinstein, M1
Kravitz, AV1
Alvarez, VA1
Oskarsson, B1
Pelak, V1
Quan, D1
Hall, D1
Foster, C1
Galetta, S1
Vorob'ev, VE1

Trials

1 trial available for gamma-aminobutyric acid and Bradykinesia

ArticleYear
[Dynamics of local oxygen consumption an extraction under the condition of altered oxygen turnover in humans during head-down bed rest].
    Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine, 2003, Volume: 37, Issue:6

    Topics: Adult; Blood Volume; gamma-Aminobutyric Acid; Humans; Hypokinesia; Male; Oxygen; Oxygen Consumption;

2003

Other Studies

5 other studies available for gamma-aminobutyric acid and Bradykinesia

ArticleYear
Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
    Neurobiology of disease, 2023, 06-15, Volume: 182

    Topics: Evoked Potentials, Motor; gamma-Aminobutyric Acid; Humans; Hypokinesia; Motor Cortex; Parkinson Dise

2023
Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
    European journal of pharmacology, 2014, Apr-05, Volume: 728

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug;

2014
The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.
    The Libyan journal of medicine, 2014, Volume: 9, Issue:1

    Topics: Alprazolam; Animals; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug;

2014
Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.
    Neuron, 2016, 05-18, Volume: 90, Issue:4

    Topics: Animals; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Globus Pallidus; Hypokinesia; Mice, Tra

2016
Stiff eyes in stiff-person syndrome.
    Neurology, 2008, Jul-29, Volume: 71, Issue:5

    Topics: Autoantibodies; Diagnosis, Differential; Disease Progression; Electromyography; Female; gamma-Aminob

2008